pharmaceutical industry management, evaluation EU-funded research, HDAC6 inhibitors
Kancera runs two small molecule drug discovery projects with epigenetic target proteins: 1. HDAC6 inhibitors against cancer 2. Histone modifying enzyme inhibitors against parasitic diseases (EU-financed A-PARADDISE project). SWElife. DEVELOPMENT OF ANTI-CANCER CANDIDATE DRUG WITH UNIQUE MECHANISM OF ACTION